Columbia University Medical Center Minority-Based Community Clinical Oncology Pro

哥伦比亚大学医学中心少数民族社区临床肿瘤学专业

• 批准号: 8523808
• 负责人: KARA M KELLY
• 金额: $ 79.63万
• 依托单位: COLUMBIA UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-08-06 至 2014-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8523808
• 关键词: Academic Medical Centers; Adverse effects; African Caribbean; Age; Award; Benefits and Risks; Cancer Burden; Cancer Control; Cancer Control Research; Catchment Area; Clinical; Clinical Oncology; Clinical Research; Clinical Sciences; Clinical Trials; Clinical Trials Cooperative Group; Communication; Communities; Community Health; Community Networks; Computer software; Controlled Study; Databases; Disease; Education; Enrollment; Foundations; Goals; Group Meetings; Health; Health Insurance Portability and Accountability Act; Herbert Irving Comprehensive Cancer Center; Hispanics; Individual; Institutional Review Boards; Life; Love; Malignant Neoplasms; Measures; Medical; Medical Oncology; Minority; Minority-Based Community Clinical Oncology Program; Mission; Modeling; Neighborhoods; New York; Office Management; Organ; Outcome; Participant; Patients; Pattern; Pediatrics; Pharmacologic Substance; Play; Population; Poverty; Prevention; Process; Questionnaires; Recruitment Activity; Registries; Research; Research Methodology; Research Personnel; Resource Sharing; Resources; Role; Science; Services; Site; Supportive care; Surgical Specialties; Tablets; Therapy Clinical Trials; Time; Training; Translational Research; Underrepresented Minority; Universities; Woman; Work; abstracting; anticancer research; base; cancer prevention; control trial; digital; effectiveness research; human subject; improved; innovative technologies; insight; interest; medical specialties; minority subjects; oncology; outreach; prevent; programs; research and development; research study; response; screening; survivorship; user-friendly; volunteer; web site

DESCRIPTION (provided by applicant): The Herbert Irving Comprehensive Cancer Center of the Columbia University Medical Center is located in northern Manhattan, New York. In our neighborhood, which is 71% Hispanic and 14% Black, 31% of residents are living below the poverty level, and cancer is the leading cause of years of potential life lost. Our challenge is therefore to develop the science and the services to prevent, control, and treat cancer in our community. Our specific objectives are: 1) to attract and educate potential study participants, especially minorities and the underserved, about participation in state-of-the-art cancer clinical research; 2) to keep participants engaged in their clinical studies and inform them of research results; 3) to provide a menu of NCI-sponsored Clinical Cooperative Group trials and pharmaceutical studies to our investigators, including those in the local medical community, for screening, prevention, cancer control, and treatments; and 4) to establish close relationships with the newly restructured NCI Clinical Cooperative Groups to enhance the benefits of clinical research. In the past three years, the RRMO and the Clinical Trials Management Office (CRMO) have combined to recruit more than 3,342 subjects to interventional studies, including, therapeutic trials, prevention and cancer control studies and survivorship initiatives. We have enrolled more than more than 2,502 minority subjects in clinical trials, most of them NCI-sponsored. Despite the effectiveness of the RRMO, it does not recruit for all studies. With an MBCCOP we will be able to expand the outreach to a broader range of participants by 1) supporting outreach recruitment to a wider range of oncology subspecialty trials, e.g. pediatrics, surgical specialties, and more medical oncology trials, etc. and 2) it will allow us to open more cancer control and prevention studies as there will be additional resources available through the MBCCOP. This will allow us to be comprehensive across the disease, age and treatment spectrum and broaden the range of organ/site specialties and to enroll still more minority patients in a wider range of cancer research trials.

描述（由申请人提供）：哥伦比亚大学医学中心的赫伯特·欧文综合癌症中心位于纽约曼哈顿北部。在我们附近的西班牙裔71％和14％黑人的附近，31％的居民生活在贫困水平以下，癌症是潜在生命多年丧生的主要原因。因此，我们的挑战是开发科学和服务，以预防，控制和治疗我们社区的癌症。我们的具体目标是：1）吸引和教育潜在的研究参与者，尤其是少数民族和服务欠缺的参与最先进的癌症临床研究； 2）让参与者从事临床研究并告知他们研究结果； 3）向包括当地医学界的研究人员提供NCI赞助的临床合作小组试验和药物研究菜单，以筛查，预防，癌症控制和治疗； 4）与新重组的NCI临床合作组建立密切的关系，以增强临床研究的益处。在过去的三年中，RRMO和临床试验管理办公室（CRMO）联合招募了3,342多名介入研究，包括治疗试验，预防和癌症控制研究和生存计划。我们已经在临床试验中招募了超过2502名少数族裔受试者，其中大多数由NCI赞助。尽管RRMO具有有效性，但并未招募所有研究。通过MBCCOP，我们将能够通过1）支持扩大范围的招聘，以将外展招聘扩展到更广泛的参与者，以提供更广泛的肿瘤学亚专业试验，例如儿科，外科专业和更多的医学肿瘤学试验等。2）这将使我们能够开放更多的癌症控制和预防研究，因为MBCCOP将有其他资源。这将使我们能够在整个疾病，年龄和治疗范围内进行全面，并扩大器官/部位专业的范围，并在更广泛的癌症研究试验中招募更多的少数族裔患者。